Dr. Adrian M. Di Bisceglie

Dr. Adrian M. Di Bisceglie

Company: HighTide Therapeutics

Job title: Chief Medical Officer


Learning About the Gut- Liver Axis as a Therapeutic Target in NASH 1:30 pm

• Describing the importance of the microbiome in health and disease • Exploring possible mechanisms by which changes in the microbiome may improve NASH • Understanding the effects of HTD1801 on human NASH – possible actions via microbiome Adrian M. Di Bisceglie, Chief Medical Officer, HighTide TherapeuticsRead more

day: Day 1 Stream 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.